Dianthus Therapeutics Inc

DNTHNASDAQ · USD
88.55USD0.00 (-2.39%)
2310

Dianthus Therapeutics Inc (DNTH) Covered Calls

As of September 25, 2026, DNTH has 111 covered call opportunities in the coming three months. Return ranges from 5.0 to 98.2% until expiration. Annualized return ranges from 23.4 to 305.8%. The nearest expiration is October 16, 2026. Maximum potential profit is $8,695.

Read more

Running DNTH covered calls helps you generate consistent income from Dianthus Therapeutics Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Dianthus Therapeutics Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best DNTH covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if DNTH stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling DNTH covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Dianthus Therapeutics Inc covered call is worth writing.

Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases. It develops DNTH103 that is in phase 1 clinical trails in patients with generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was incorporated in 2015 and is based in New York, New York.

Income-focused investors, long-term DNTH holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling DNTH covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Dianthus Therapeutics Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile90.08% Elevated
  • Market cap (M$)4,953
  • 52 weeks high-24.88%
  • 52 weeks low174.83%
  • Analyst recommendationStrong Buy
    1.06
  • Target price$140.12
    58.24% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-05
  • P/E—
  • Future P/E—
  • EPS (ttm)-4.15
  • EPS growth next 5 years-10.19%

As of September 25, 2026

2026-11-2056130.0046.810.104.904155.0046.92305.84-0.11+0.1814.80
2027-01-15112165.0086.340.104.907655.0086.45281.73-0.11+0.1404.80
2026-11-2056125.0041.160.504.903695.0041.73271.98-0.56+0.1914.40
2027-01-15112160.0080.690.104.907155.0080.80263.33-0.11+0.1534.80
2027-01-15112155.0075.040.104.906655.0075.16244.93-0.11+0.1524.80
2026-11-2056120.0035.521.505.503295.0037.21242.53-1.69+0.24344.00
2026-10-1621100.0012.930.304.901175.0013.27230.63-0.34+0.281774.60
2027-02-19147170.0091.980.104.908155.0092.09228.67-0.11+0.1404.80
2027-01-15112150.0069.400.604.906205.0070.07228.36-0.68+0.1614.30
2027-02-19147165.0086.340.304.907675.0086.67215.21-0.34+0.1514.60

As of September 25, 2026

Sell covered calls with the data behind you

Find the best DNTH covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial